iAnthus Capital Holdings, Inc. (ITHUF) Stock Analysis
Educational signal · not a buy or sell recommendation · How to read this
P/E 16.70 means the share price is 16.70 times one year of earnings per share; the S&P 500 usually sits near 20-25. Market cap $27.9M is the value of all shares combined.
For informational purposes only. Not financial advice. Machine-generated analysis by Stock Expert AI — model gemini-2.0-flash, generated Mar 16, 2026. Editorial oversight is systemic, not page-by-page. Editorially accountable: Sedat ANAK, Founder and Editor-in-Chief. Data sources: Financial Modeling Prep, Yahoo Finance, SEC EDGAR
Quick AnsweriAnthus Capital Holdings, Inc. (ITHUF) trades at $0.004. iAnthus Capital Holdings, Inc. cultivates, processes, and retails cannabis products in the United States. Market cap: $27.9M, Sector: Healthcare.
Price as of Sep 11, 2026 · Last analyzed: Mar 16, 2026Analyst Coverage for ITHUF: ITHUF does not currently have published analyst price targets in our coverage universe. This is common for smaller-cap names with limited Wall Street coverage. In the absence of analyst consensus, our AI model evaluates ITHUF against Healthcare peers across nine fundamental dimensions and assigns a neutral fundamental signal based on the underlying data.
No score published: we hold no usable price for this ticker, and a grade beside a missing price says nothing.
ITHUF: this read rests on a single discipline (Munger composite) — the other council disciplines have no scored data yet.
How is this calculated? →iAnthus Capital Holdings, Inc. (ITHUF) Healthcare & Pipeline Overview
iAnthus Capital Holdings, Inc. operates in the U.S. cannabis market, focusing on cultivation, processing, and retail. With a portfolio of dispensaries and cultivation facilities, the company offers diverse cannabis and CBD products, including pre-rolls, edibles, and topicals, positioning itself in a competitive and evolving industry landscape.
What Is the Investment Thesis for ITHUF?
iAnthus Capital Holdings, Inc. presents a speculative investment opportunity within the evolving cannabis market. With a market capitalization of $27.9M and a P/E ratio of 16.70, the company operates with a profit margin of 1.1% and a gross margin of 46.3%. Key value drivers include expansion of its dispensary network and increased production capacity. Growth catalysts involve potential regulatory changes at the state and federal levels, which could broaden market access. However, potential risks include intense competition, fluctuating cannabis prices, and the ongoing need to raise capital. Investors should closely monitor the company's ability to improve profitability and navigate the complex regulatory environment.
Based on FMP financials and quantitative analysis
ITHUF Key Highlights
Market Cap of $27.9M indicates a small-cap company with potential for high growth but also higher risk.
- P/E Ratio of 16.70 suggests the company is trading at a reasonable valuation compared to its earnings.
- Gross Margin of 46.3% demonstrates the company's ability to maintain profitability after accounting for the cost of goods sold.
- Profit Margin of 1.1% indicates the company's net income is a small percentage of its revenue, suggesting potential areas for improvement in cost management.
- Beta of -0.99 suggests the stock price is negatively correlated with the market, potentially offering diversification benefits.
Who Are ITHUF's Competitors?
ITHUF is benchmarked below against 8 industry peers on price, market cap, and our AI MoonshotScore.
| Company | Price | Change | Market Cap | MoonshotScore |
|---|---|---|---|---|
| CANSF Atlas Energy Corp. | $0.08 | -7.66% | $27.6M | — |
| CNTMF Fluent Corp. | $0.02 | +4.65% | $10.5M | — |
| CORBF Global Cord Blood Corporation | $0.95 | 0.00% | $127M | — |
| PLNH Planet 13 Holdings Inc. | $0.13 | -7.14% | $42.7M | 429-signal |
| DBCCF Decibel Cannabis Company Inc. | $1.27 | -3.39% | $49.0M | 459-signal |
| AVCNF Avicanna Inc. | $0.08 | 0.00% | $10.6M | 529-signal |
| ZYBT Zhengye Biotechnology Holding Limited | $1.59 | +1.27% | $75.4M | 465-pillar |
| CWBHF Charlotte's Web Holdings, Inc. | $0.35 | +6.23% | $93.9M | 519-signal |
AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance This table mixes two scoring engines — compare a number only with others carrying the same tag.
What Are ITHUF's Key Strengths?
Vertically integrated operations.
- Diverse product portfolio.
- Established presence in key markets.
- Licensed cultivation and dispensary facilities.
What Are ITHUF's Weaknesses?
Limited financial resources.
- Low profit margins.
- Dependence on regulatory changes.
- High debt levels.
What Could Drive ITHUF Stock Higher?
Potential regulatory changes at the state and federal levels could expand market access.
- Expansion of dispensary network in key markets.
- Development and launch of new cannabis products.
- Strategic partnerships and acquisitions to enhance capabilities.
- Lobbying and advocacy for regulatory reform.
What Are the Key Risks for ITHUF?
Financial-distress signal — its Altman Z-Score of -8.29 sits in the distress zone (elevated bankruptcy risk).
- Weak fundamentals — a Piotroski F-Score of 2/9 flags soft profitability, leverage or efficiency.
- Intense competition from established players and new entrants.
- Fluctuating cannabis prices impacting revenue and profitability.
- Complex and evolving regulatory landscape creating compliance challenges.
- Limited access to capital and potential dilution of shareholder value.
- Negative public perception and social stigma associated with cannabis.
What Are the Growth Opportunities for ITHUF?
- Expansion of Dispensary Network: iAnthus has the opportunity to increase its market presence by expanding its dispensary network in existing and new states. The U.S. cannabis dispensary market is projected to reach $38 billion by 2028. Strategic expansion into high-growth markets, such as New Jersey and New York, could significantly boost revenue. This expansion requires securing licenses, acquiring real estate, and building out retail operations, with a timeline of 1-3 years for substantial impact.
- Increased Production Capacity: Enhancing cultivation and processing capacity is crucial for meeting growing demand and improving cost efficiency. Investing in advanced cultivation technologies and expanding existing facilities can increase yields and reduce production costs. The market for cannabis cultivation is expected to grow as demand increases. This initiative requires capital investment and technological upgrades, with an estimated timeline of 1-2 years to realize significant benefits.
- Product Innovation and Diversification: Developing new and innovative cannabis products can attract new customers and increase market share. Focusing on high-margin products, such as concentrates, edibles, and topicals, can improve profitability. The market for cannabis-infused products is rapidly expanding, with edibles and topicals gaining popularity. This strategy requires research and development, product testing, and marketing efforts, with a timeline of 6-18 months for new product launches.
- Strategic Partnerships and Acquisitions: Forming strategic partnerships with other cannabis companies or acquiring complementary businesses can expand iAnthus's capabilities and market reach. Collaborations with established brands or technology providers can enhance product offerings and operational efficiency. The cannabis industry is consolidating, with larger companies acquiring smaller players. This approach requires careful due diligence and integration planning, with a timeline of 1-3 years for successful partnerships and acquisitions.
- Lobbying and Advocacy for Regulatory Reform: Actively lobbying for regulatory reform at the state and federal levels can create a more favorable operating environment for iAnthus. Advocating for policies that reduce taxes, streamline licensing processes, and allow interstate commerce can significantly improve the company's profitability and growth prospects. The regulatory landscape is constantly evolving, with potential for federal legalization or decriminalization. This effort requires engaging with policymakers and industry associations, with an ongoing timeline for influencing regulatory outcomes.
What Are ITHUF's Competitive Advantages?
- Licensed cultivation and dispensary operations create barriers to entry.
- Established brand recognition in key markets.
- Vertically integrated business model provides control over the supply chain.
- Proprietary formulations and product innovations.
What Does ITHUF Do?
Founded in 2014, iAnthus Capital Holdings, Inc. has established itself as a player in the U.S. cannabis industry. The company owns and operates licensed cannabis cultivation, processing, and dispensary facilities across multiple states. Its product offerings span a wide array of cannabis and cannabidiol (CBD) products, catering to both recreational and medicinal users. These include biomass products like pre-rolls, cannabis-infused products such as topical creams and edibles, vape cartridges, concentrates, live resins, wax products, oils, and tinctures. Additionally, iAnthus provides CBD products like topical creams, tinctures, and sprays, along with beauty and skincare items, including lotions, creams, haircare products, lip balms, and bath bombs. The company engages in both wholesale distribution and retail sales of its CBD products. Currently, iAnthus owns and/or operates 32 dispensaries and 10 cultivation and/or processing facilities in 8 states, reflecting its integrated approach to the cannabis value chain. Headquartered in New York, iAnthus continues to navigate the evolving regulatory landscape of the cannabis industry, seeking opportunities for growth and expansion.
What Products and Services Does ITHUF Offer?
- Cultivates cannabis plants in licensed facilities.
- Processes raw cannabis into various products.
- Operates retail dispensaries for direct sales to consumers.
- Offers a range of cannabis products, including pre-rolls, edibles, and concentrates.
- Distributes CBD products through wholesale channels.
- Develops and sells cannabis-infused products like topicals and oils.
- Engages in research and development for new cannabis products.
How Does ITHUF Make Money?
- Vertically integrated model encompassing cultivation, processing, and retail.
- Generates revenue through direct sales at dispensaries.
- Wholesale distribution of CBD products to retailers.
- Focuses on both recreational and medicinal cannabis markets.
What Industry Does ITHUF Operate In?
iAnthus Capital Holdings, Inc. operates within the rapidly expanding cannabis industry, which is characterized by evolving regulations and increasing consumer acceptance. The U.S. cannabis market is projected to reach significant growth over the next decade, driven by the legalization of recreational and medicinal cannabis in more states. The competitive landscape includes both large multi-state operators and smaller regional players. iAnthus's integrated business model, encompassing cultivation, processing, and retail, positions it to capture value across the supply chain. However, the company faces competition from established players and new entrants, as well as challenges related to regulatory compliance and market volatility.
Who Are ITHUF's Key Customers?
- Recreational cannabis users seeking various cannabis products.
- Medicinal cannabis patients with qualifying conditions.
- Retailers purchasing CBD products for resale.
- Consumers interested in cannabis-infused beauty and skincare products.
Research confidence
Enough evidence to be useful, with gaps worth knowing about.
- ● Scoring coverage unknown
- ● Price is current
- ● Latest filing 30 days ago
- ● No analyst coverage
MoonshotScore History
Recorded daily since 2026-08-23 · 19 snapshots
| 2026-08-23 | 45 |
| 2026-08-26 | 45 |
| 2026-08-29 | 45 |
| 2026-09-01 | 45 |
| 2026-09-04 | 45 |
| 2026-09-07 | 45 |
| 2026-09-10 | 45 |
What changed?
The score has stayed at 45.
Over the same 18 days the stock moved +25.0%.
Company Profile
iAnthus Capital Holdings, Inc. operates in the Drug Manufacturers - Specialty & Generic industry within the Healthcare sector. It is headquartered in Toronto, CA. The company is led by CEO Richard Proud. ITHUF has traded publicly since 2018.
iAnthus Capital Holdings, Inc. Financial Trajectory
iAnthus Capital Holdings, Inc. (ITHUF) reported $35.3M in revenue for Q2 FY2026, reflecting 5.5% growth compared to the prior quarter. The company recorded a net loss of $14.4M, with diluted EPS of $-0.00. Quarter-over-quarter revenue has been mixed, typical for a micro-cap company operating in Healthcare. Across the four most recent quarters, ITHUF averaged $-0.00 in diluted EPS.
How iAnthus Capital Holdings, Inc. Is Valued
iAnthus Capital Holdings, Inc. carries a market capitalization of $27.9M, placing it in the micro-cap category.
Key Financial Metrics
Return on equity for iAnthus Capital Holdings, Inc. stands at 61.6%, a gauge of how efficiently it converts shareholder capital into profit. Return on assets is -23.3%, showing how much profit it generates from its asset base. Its free cash flow yield is -57.2%, a gauge of the cash the business throws off relative to its market value. A current ratio of 0.59 means current liabilities exceed short-term assets, a liquidity point worth watching. Its earnings yield is -171.4%, the inverse of the P/E and a quick read on earnings relative to price.
Financial Health
iAnthus Capital Holdings, Inc.'s Piotroski F-Score is 2/9, a 9-point checklist of profitability, leverage and efficiency — flagging fundamental weakness worth scrutiny. Its Altman Z-Score of -8.29 places it in the distress zone, a signal of elevated financial risk.
Earnings Track Record
iAnthus Capital Holdings, Inc. has beaten Wall Street's EPS estimate in 3 of its last 3 reported quarters — a consistent record of delivering on expectations. Reported results have landed about 97.8% above estimates on average.
ITHUF Financials
Fundamental Snapshot
Based on FMP financials and quantitative analysis · FY 2025
Bull Case vs Bear Case
Bull Case
- Vertically integrated operations.
- Diverse product portfolio.
- Established presence in key markets.
- Licensed cultivation and dispensary facilities.
Bear Case
- Limited financial resources.
- Low profit margins.
- Dependence on regulatory changes.
- High debt levels.
AI-generated arguments based on insider flow, news sentiment and technicals — not financial advice · March 2026
Recent Quarterly Results
| Quarter | Revenue | Net Income | EPS |
|---|---|---|---|
| Q2 FY2026 | $35M | -$14M | -$0.0021 |
| Q1 FY2026 | $34M | -$14M | -$0.0020 |
| Q4 FY2025 | $36M | -$14M | -$0.0021 |
| Q3 FY2025 | $35M | -$13M | -$0.0019 |
Q2 FY2026 · filed 12 Aug 2026 · SEC EDGAR →
Based on FMP financials and quantitative analysis
ITHUF Latest News
-
iAnthus Reports Fiscal Second Quarter 2026 Financial Results and US$2.5 Million Revolving Line of Credit
globenewswire.com · Aug 12, 2026
-
Washington Post Reported President Trump Expected To Announce A Medicare Pilot Program To Reimburse Patients' CBD Treatments
benzinga · Dec 18, 2025
-
'Trump to sign executive order reclassifying marijuana: Officials' -ABC Report
benzinga · Dec 17, 2025
-
Hess Midstream Signs $100M Repurchase That Includes Class B Units Of Hess Midstream Operations From chevron Affiliate And Hess Midstream's Class A Shares From Public
benzinga · Aug 5, 2025
ITHUF Analyst Consensus
Consensus Rating
Aggregated Buy/Hold/Sell recommendations collected by Financial Modeling Prep for ITHUF.
Price Targets
Wall Street price target analysis for ITHUF.
ITHUF MoonshotScore
MoonshotScore is Stock Expert AI's proprietary 0-100 research rating, not a buy or sell recommendation. No MoonshotScore is published for ITHUF; grades run from A+ (80-100) to F (below 30).
Latest News
iAnthus Reports Fiscal Second Quarter 2026 Financial Results and US$2.5 Million Revolving Line of Credit
Washington Post Reported President Trump Expected To Announce A Medicare Pilot Program To Reimburse Patients' CBD Treatments
'Trump to sign executive order reclassifying marijuana: Officials' -ABC Report
Hess Midstream Signs $100M Repurchase That Includes Class B Units Of Hess Midstream Operations From chevron Affiliate And Hess Midstream's Class A Shares From Public
Leadership: Richard Proud
CEO
Richard Proud serves as the CEO of iAnthus Capital Holdings, Inc. His professional background includes experience in management and operations. He is responsible for overseeing the company's strategic direction and day-to-day operations. His leadership is focused on driving growth and profitability in the competitive cannabis market. He manages a workforce of 716 employees.
Track Record: Since assuming the role of CEO, Richard Proud has focused on streamlining operations and expanding the company's market presence. Key milestones under his leadership include optimizing cultivation processes and enhancing the retail experience at iAnthus dispensaries. He has also worked to navigate the complex regulatory environment and secure licenses for new facilities.
ITHUF OTC Market Information
The OTC Other tier, where iAnthus Capital Holdings, Inc. trades, represents the lowest tier of the over-the-counter (OTC) market. Companies in this tier often have limited financial disclosure and may not meet the listing requirements of major exchanges like the NYSE or NASDAQ. This tier is generally considered more speculative due to the higher risk associated with less stringent regulatory oversight and reporting standards compared to listed exchanges. Investors should exercise caution and conduct thorough due diligence before investing in companies on the OTC Other tier.
- OTC Tier: OTC Other
- Limited Financial Disclosure: Lack of comprehensive and timely financial reporting increases investment risk.
- Low Liquidity: Reduced trading volume and wider bid-ask spreads can lead to price volatility.
- Regulatory Uncertainty: OTC-listed companies are subject to less regulatory oversight, increasing the risk of fraud or mismanagement.
- Going Concern Risk: Companies on the OTC Other tier may face challenges in maintaining operations and meeting financial obligations.
- Dilution Risk: OTC companies may raise capital through dilutive stock offerings, impacting shareholder value.
- Verify the company's legal status and registration.
- Review available financial statements and disclosures.
- Assess the company's management team and track record.
- Evaluate the company's business model and competitive position.
- Understand the risks associated with the OTC market.
- Check for any regulatory actions or legal proceedings.
- Consult with a financial advisor.
- Established operations with licensed facilities.
- Presence in multiple states with regulatory approvals.
- Audited financial statements (if available).
- Active management team with industry experience.
- Positive media coverage and investor relations efforts.
Common Questions About ITHUF (Healthcare)
Is ITHUF a good stock?
Stock Expert AI does not rate ITHUF buy, sell or hold. iAnthus Capital Holdings, Inc. has no MoonshotScore yet; read the financial checkup, analyst consensus and risks directly. Whether it fits is your call: check what it sells, whether it earns, what the price assumes, and what would prove you wrong.
What do analysts say about ITHUF stock?
Analyst coverage of ITHUF stock is limited due to its OTC listing and smaller market capitalization. However, analysts generally focus on the company's growth potential within the expanding cannabis market. Key valuation metrics include revenue growth, gross margin, and EBITDA.
What are the key factors to evaluate for ITHUF?
Evaluate ITHUF on fundamentals, analyst consensus, and risk factors. With a market capitalization of $27.9M and a P/E ratio of 16.70, the company operates with a profit margin of 1.1% and a gross margin of 46.3%. Not financial advice.
How frequently does ITHUF data refresh on this page?
ITHUF's price was last updated on Sep 11, 2026 and refreshes on page view during U.S. market hours; the quote is a provider snapshot, not an exchange feed. Fundamentals update after quarterly filings; the MoonshotScore recalculates nightly; news aggregates continuously.
What has driven ITHUF's recent stock price performance?
iAnthus Capital Holdings, Inc. (ITHUF) moves on earnings results, analyst revisions, sector rotation, and market sentiment. Notable catalyst: Vertically integrated operations. See the News tab for the latest drivers. Past performance does not predict future results.
Should investors consider ITHUF overvalued or undervalued right now?
iAnthus Capital Holdings, Inc. (ITHUF) has no trailing P/E available here, so lean on price-to-sales and cash flow in the Financials tab. Compare P/E, P/S, and EV/EBITDA against sector peers for a full view.
Can I buy fractional shares of ITHUF?
Yes, most major brokerages offer fractional shares of iAnthus Capital Holdings, Inc. (ITHUF) with no minimum purchase requirement. This means you can invest any dollar amount regardless of the share price. Check your brokerage platform for specific terms, fees, and fractional share availability.
How can I track ITHUF's earnings and financial reports?
iAnthus Capital Holdings, Inc. (ITHUF) reports quarterly earnings approximately 4-6 weeks after each fiscal quarter ends. You can track earnings dates, revenue and EPS estimates, and actual results on this page's Financials tab. Earnings surprises (beats or misses) often cause significant short-term price moves. Your brokerage can send alerts for ITHUF earnings announcements.
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Official Resources
Data provided for informational purposes only.
- Limited analyst coverage due to OTC listing.
- Financial data may be less comprehensive than for exchange-listed companies.
- Forward-looking statements involve risks and uncertainties.